Neuroimaging – News and Features

Research explores overlapping and unique brain features in insomnia, depression and anxiety using brain scans. The findings reveal shared brain mechanisms, such as reduced cerebral cortex area.

The D-PSCAN method, developed for live NTS imaging, enables high-resolution, minimally invasive observation of the NTS’s neural activity in living mice. The technique provides insights into emotion regulation.

New research shows that preterm infants born to mothers with preeclampsia or hypertension suffer from brain injuries and neurodevelopmental delays. The study found that these infants had lower cognitive and language scores at age 2.

Scientists at the University of East Anglia have developed a revolutionary new way of uncovering the "true age" of your heart using MRI.

A new atlas of the mouse brain has been developed that will increase precision in measuring changes in brain structure and make it easier to share results for scientists working to understand neurological diseases such as Alzheimer's disease.

A study found that increasing physical activity in middle-aged adults can reduce Alzheimer's risk by lowering beta-amyloid accumulation in the brain. The research highlighted the benefits of even minimal exercise.

A study on Autism Spectrum Disorder (ASD) reveals that immune cells, specifically macrophages, play a critical role in synaptic pruning. Researchers found that macrophages from individuals with ASD were less effective at clearing synaptic material.

In a pilot study testing psilocybin therapy in Parkinson's patients, the participants experienced clinically significant improvements in mood, cognition and motor function that lasted for weeks after the drug was out of their systems.

A study shows that low-intensity focused ultrasound technology can safely and effectively target the amygdala, reducing symptoms of depression, anxiety and PTSD. Patients experienced improvements after just three weeks of daily treatment.

A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage caused by certain cancer treatments.